Growth Metrics

Armata Pharmaceuticals, Inc. (ARMP) Operating Expenses (2016 - 2018)

Armata Pharmaceuticals' Operating Expenses history spans 6 years, with the latest figure at $9.9 million for Q4 2018.

  • For Q4 2018, Operating Expenses rose 315.68% year-over-year to $9.9 million; the TTM value through Dec 2018 reached $18.2 million, up 12.11%, while the annual FY2024 figure was $47.6 million, 4.82% up from the prior year.
  • Operating Expenses for Q4 2018 was $9.9 million at Armata Pharmaceuticals, up from $2.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $11.9 million in Q4 2016 and bottomed at $41000.0 in Q3 2016.
  • The 5-year median for Operating Expenses is $2.8 million (2018), against an average of $4.0 million.
  • The largest annual shift saw Operating Expenses plummeted 98.41% in 2016 before it skyrocketed 1812.2% in 2017.
  • A 5-year view of Operating Expenses shows it stood at $2.7 million in 2014, then dropped by 4.71% to $2.6 million in 2015, then soared by 362.31% to $11.9 million in 2016, then crashed by 79.93% to $2.4 million in 2017, then surged by 315.68% to $9.9 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Operating Expenses are $9.9 million (Q4 2018), $2.4 million (Q3 2018), and $2.8 million (Q2 2018).